John N. van den Anker

9.8k citations

180 papers · 6.7k indexed · 2 hit papers · h-index 43

Pediatrics, Perinatology and Child Health top 0.1%
Pharmacology top 0.5%
Public Health, Environmental and Occupational Health top 1%
Epidemiology top 5%
Infectious Diseases top 2%

Co-authors: Karel Allegaert Johan W. Mouton Dick Tibboel Matthijs de Hoog Natella Rakhmanina Jan Lindemans Kathleen Neville Ian M. Paul
Topics: Pharmaceutical studies and practices (59 papers)Antibiotics Pharmacokinetics and Efficacy (40 papers)Pediatric Pain Management Techniques (17 papers)
Cited by: Pediatrics, Perinatology and Child Health Pharmacology
Journals: JAMA PEDIATRICS Advanced Energy Materials
Partner nations: United States Netherlands Switzerland

In The Last Decade

John N. van den Anker

176 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neonatal Drug Withdrawal

2012 623 citations John N. van den Anker et al. profile →
Off-Label Use of Drugs in Children

2014 262 citations John N. van den Anker et al. profile →

Peers

Countries citing papers authored by John N. van den Anker

Since Specialization

Citations

This map shows the geographic impact of John N. van den Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. van den Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. van den Anker more than expected).

Fields of papers citing papers by John N. van den Anker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. van den Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. van den Anker. The network helps show where John N. van den Anker may publish in the future.

Co-authorship network of co-authors of John N. van den Anker

This figure shows the co-authorship network connecting the top 25 collaborators of John N. van den Anker. A scholar is included among the top collaborators of John N. van den Anker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N. van den Anker. John N. van den Anker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Silicon‐Inspired Analysis of Interfacial Recombination in Perovskite Photovoltaics 2024 ·Advanced Energy Materials ·(unknown),(unknown),(unknown),John N. van den Anker,(unknown),Gianluca Coletti,Erik C. Garnett	8
2	No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis 2024 ·Human Reproduction Open ·Alexander Katalinic,(unknown),Juan A. García-Velasco,L.P. Shulman,John N. van den Anker,Jerome F. Strauss	5
3	Effective Hydrogenation of Poly-Si Passivating Contacts by Atomic-Layer-Deposited Nickel Oxide 2022 ·IEEE Journal of Photovoltaics ·Nga Phung,(unknown),W. Beyer,John N. van den Anker,Ronald C. G. Naber,(unknown),W. M. M. Kessels,L.J. Geerligs,Mariadriana Creatore,Bart Macco	7
4	Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why? 2022 ·Neonatology ·Cornelis Smit,(unknown),Samira Samiee‐Zafarghandy,(unknown),Sinno H. P. Simons,Robert B. Flint,Marc Pfister,Catherijne A. J. Knibbe,John N. van den Anker	4
5	Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir 2021 ·Clinical Pharmacokinetics ·(unknown),Jeremiah D. Momper,Natella Rakhmanina,Dionna J. Green,Gilbert J. Burckart,Tim R. Cressey,Mark Mirochnick,Brookie M. Best,John N. van den Anker,André Dallmann	17
6	Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women 2019 ·Clinical Pharmacokinetics ·Paola Mian,John N. van den Anker,Kristel Van Calsteren,Pieter Annaert,Dick Tibboel,Marc Pfister,Karel Allegaert,André Dallmann	48
7	Phenobarbital Increases Midazolam Clearance in Neonates Treated with Hypothermia: Do We Really Need to Know? 2019 ·Neonatology ·Karel Allegaert,Anne Smits,John N. van den Anker	1
8	Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study 2018 ·Clinical Pharmacokinetics ·(unknown),Sarah F. Cook,Shaun S. Kumar,Xiaoxi Liu,Diana G. Wilkins,Roger Gaedigk,Andrea Gaedigk,Catherine M.T. Sherwin,John N. van den Anker	13
9	Randomized Controlled Trial Comparing Different Single Doses of Intravenous Paracetamol for Placement of Peripherally Inserted Central Catheters in Preterm Infants 2017 ·Neonatology ·Daniëlla Roofthooft,Sinno H. P. Simons,Richard A. van Lingen,Dick Tibboel,John N. van den Anker,(unknown),Monique van Dijk	16
10	Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use 2016 ·Journal of Pharmacy and Pharmacology ·Anne Smits,John N. van den Anker,Karel Allegaert	11
11	Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC 2016 ·Current Medicinal Chemistry ·Jasna Jančić,(unknown),Nikola Ivančević,(unknown),John N. van den Anker,Janko Samardžić	5
12	Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry: Method validation and application to a neonatal pharmacokinetic study 2015 ·Journal of Chromatography B ·Sarah F. Cook,(unknown),John N. van den Anker,Diana G. Wilkins	52
13	A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults 2013 ·Clinical Pharmacokinetics ·Ibrahim Ince,Saskia N. de Wildt,(unknown),Mariska Y. M. Peeters,Jacobus Burggraaf,Évelyne Jacqz-Aigrain,John N. van den Anker,Dick Tibboel,Meindert Danhof,Catherijne A. J. Knibbe	34
14	An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit 2012 ·The Journal of Clinical Pharmacology ·Wei Du,Victoria Tutag Lehr,Mary Lieh‐Lai,Winston Koo,Robert M. Ward,Michael Rieder,John N. van den Anker,Jaxk Reeves,(unknown),Mirjana Lulic‐Botica,Jacob V. Aranda	55
15	CYP3A5, ABCB1, and SLCO1B1 Polymorphisms and Pharmacokinetics and Virologic Outcome of Lopinavir/Ritonavir in HIV-Infected Children 2011 ·Therapeutic Drug Monitoring ·Natella Rakhmanina,Michael Neely,Ron H. N. van Schaik,Heather Gordish‐Dressman,(unknown),Steven J. Soldin,John N. van den Anker	28
16	Nevirapine Concentration in Nonstimulated Saliva: An Alternative to Plasma Sampling in Children with Human Immunodeficiency Virus Infection 2007 ·Therapeutic Drug Monitoring ·Natella Rakhmanina,Edmund V. Capparelli,John N. van den Anker,(unknown),John L. Sever,Hans Spiegel,Steven J. Soldin	17
17	Analgesic trials in neonates: observations, pitfalls and recommendations. 2005 ·EUR Research Repository (Erasmus University Rotterdam) ·Monique van Dijk,Dick Tibboel,John N. van den Anker,Sinno H. P. Simons	2
18	Review : Therapeutic Drug Monitoring of Antiretroviral Therapy 2004 ·AIDS Patient Care and STDs ·Natella Rakhmanina,John N. van den Anker,Steven J. Soldin	14
19	Paracetamol and metabolite pharmacokinetics in infants 2003 ·European Journal of Clinical Pharmacology ·Caroline D. van der Marel,Brian J. Anderson,Richard A. van Lingen,Nicholas H. G. Holford,(unknown),Frank G. A. Jansman,John N. van den Anker,Dick Tibboel	66
20	Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants 2003 ·British Journal of Anaesthesia ·N.J. Bouwmeester,John N. van den Anker,Wim C.J. Hop,K.J.S. Anand,Dick Tibboel	77

About John N. van den Anker

John N. van den Anker is a scholar working on Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine and Pharmacology, having authored 180 papers that have together received 6.7k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (59 papers), Antibiotics Pharmacokinetics and Efficacy (40 papers) and Pediatric Pain Management Techniques (17 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.6k citations), Pharmacology (1.6k citations) and Pharmacology (782 citations). John N. van den Anker has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Karel Allegaert, Johan W. Mouton, Dick Tibboel, Matthijs de Hoog, Natella Rakhmanina, Jan Lindemans, Kathleen Neville, Ian M. Paul, Thomas P. Green and Jeffrey L. Galinkin. Their work appears in journals such as JAMA, PEDIATRICS and Advanced Energy Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact